

Determining the optimal sequencing of bispecifics and CAR-T cells in multiple myeloma
Aug 3, 2023
Experts Salomon Manier, Surbhi Sidana, and Hermann Einsele discuss the optimal sequencing of bispecific antibodies and CAR-T cells in multiple myeloma, highlighting data from recent clinical trials. They explore mechanisms of resistance, factors to consider when sequencing, and potential sequencing strategies, recommending CAR-T cell therapy followed by bispecific antibodies based on emerging data.
Chapters
Transcript
Episode notes